While our data suggest that Cry1 may be a potential novel therapeutic target to combat diet-induced obesity, future studies will be needed to determine if a pharmacological manipulation of Cry1 also prevents weight gain. This evidence concerns the gene CRY1 and obesity due to melanocortin 4 receptor deficiency.